COVID-19 VACCINATIONS: If, in addition to indemnity for your main employment, you would like cover for delivering COVID-19 Vaccinations please apply for our standalone extension Apply Today

Home  »   Latest News   »   Pharmacists in England are invited to complete the Prescription Charges survey 2024

Pharmacists in England are invited to complete the Prescription Charges survey 2024

As a member of the Prescription Charges Coalition (PCC), the PDA is asking pharmacists in England to complete a survey about their experiences of patients denying prescriptions due to financial issues.

Tue 16th January 2024 The PDA

The PDA and Royal Pharmaceutical Society (RPS) are both members of the PCC, a group of 51 organisations calling on the government to scrap prescription charges for people with long-term conditions in England.

The coalition is made up primarily of patient organisations representing those who require medicines to be prescribed because of their long-term medical conditions. All members of the coalition understand that if patients in England cannot afford their prescriptions, the consequences of individuals not receiving their prescribed medicines can increase costs for the NHS because their health may deteriorate as a result.

For example, research published in May 2018 by the York Health Economics Consortium (YHEC) found that abolishing prescription charges for people with just two of the long-term conditions represented in the coalition – Inflammatory Bowel Disease (Crohn’s Disease and Ulcerative Colitis) and Parkinson’s – would save the NHS over £20 million a year.

Examples reported by pharmacists include patients refusing to take prescriptions for stomach protection, such as Omeprazole or Lansoprazole, when prescribed in conjunction with strong anti-inflammatory tablets such as Naproxen, which can lead to an increased risk of developing a stomach ulcer.

There have also been reports of patients with asthma, a long-term respiratory condition, refusing steroid inhalers due to cost and rationing their reliever inhalers instead, despite the advice of the pharmacist. This has a considerable effect on their long-term health.

As part of its ongoing support for the coalition, the PDA is asking pharmacists about their experience of patients partially or fully declining to have prescriptions dispensed because of the cost.

Members who have practiced in England within the last 12 months are asked to please complete the below survey by Sunday 28 January.

COMPLETE THE SURVEY

Learn more

Not yet a PDA member?

If you have not yet joined the PDA, we encourage you to join today and ask your colleagues to do the same.

Membership is FREE to pharmacy students, trainee pharmacists, and for the first three months of being newly qualified.

JOIN THE PDA TODAY

Read about our key member benefits here.

 

 

 

 

The Pharmacists' Defence Association is a company limited by guarantee. Registered in England; Company No 4746656.

The Pharmacists' Defence Association is an appointed representative in respect of insurance mediation activities only of
The Pharmacy Insurance Agency Limited which is registered in England and Wales under company number 2591975
and is authorised and regulated by the Financial Conduct Authority (Register No 307063)

The PDA Union is recognised by the Certification Officer as an independent trade union.

Cookie Use

This website uses cookies to help us provide the best user experience. If you continue browsing you are giving your consent to our use of cookies.

General Guidance Resources Surveys PDA Campaigns Regulations Locums Indemnity Arrangements Pre-Regs & Students FAQs Coronavirus (COVID-19)